Neurophysiological, biomolecular and psychological predictors of response to Erenumab in chronic migraine

被引：0
|
作者：
Fiamingo, G. [1 ]
De Icco, R. [1 ]
Greco, R. [2 ]
Zanaboni, A. M. [3 ]
Bottiroli, S. [4 ]
Guaschino, E. [5 ]
Allena, M. [5 ]
Grillo, V. [5 ]
Tassorelli, C. [1 ]
Sancess, G. [5 ]
机构：
[1] Univ Pavia, IRCCS Mondino Fdn, Headache Sci Ctr, Dept Brain & Behav Sci, Pavia, Italy
[2] IRCCS Mondino Fdn, Lab Neurophysiol Integrat Auton Syst, Pavia, Italy
[3] Univ Pavia, IRCCS Mondino Fdn, Dept Brain & Behav Sci, Lab Neurophysiol Integrat Auton Syst, Pavia, Italy
[4] Giustino Fortunato Univ, IRCCS Mondino Fdn, Fac Law, Headache Sci Ctr, Pavia, Italy
[5] IRCCS Mondino Fdn, Headache Sci Ctr, Pavia, Italy
来源：
EUROPEAN JOURNAL OF NEUROLOGY | 2020年 / 27卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
EPO1153
引用
收藏
页码：612 / 612
页数：1
相关论文
共 50 条
  • [21] Effectiveness of erenumab in chronic migraine in a tertiary headache centre
    Khalil, Modar
    Moreno-Ajona, David
    Greenwood, Fiona
    Hoffmann, Jan
    Goadsby, Peter J.
    CEPHALALGIA, 2019, 39 : 269 - 270
  • [22] Efficacy of erenumab for the treatment of patients with chronic migraine and aura
    Ashina, Messoud
    Dodick, David
    Goadsby, Peter J.
    Kudrow, David
    Reuter, Uwe
    Tepper, Stewart J.
    Cheng, Sunfa
    Leonardi, Dean
    Lenz, Robert A.
    Mikol, Daniel D.
    CEPHALALGIA, 2017, 37 : 34 - 35
  • [23] Predictors of early response to onabotulinumtoxin type a in chronic migraine
    Mas-Sala, N.
    Quintana, M.
    Alvarez-Sabin, J.
    Pozo-Rosich, P.
    JOURNAL OF HEADACHE AND PAIN, 2014, 15
  • [24] PREDICTORS OF RESPONSE TO BOTULINUM NEUROTOXIN (BONT) IN CHRONIC MIGRAINE
    Pozo-Rosich, Patricia
    TOXICON, 2018, 156 : S93 - S93
  • [25] Efficacy of Erenumab in chronic migraine patients with and without allodynia
    Lipton, R.
    Buse, D.
    Dodick, D.
    Richards, S.
    Klatt, J.
    Mikol, D. D.
    Cheng, S.
    Chou, D.
    Snellman, J.
    EUROPEAN JOURNAL OF NEUROLOGY, 2019, 26 : 219 - 219
  • [26] Efficacy of Erenumab in Chronic Migraine Patients With and Without Allodynia
    Chou, Denise
    Buse, Dawn
    Dodick, David
    Richards, Sharon
    Klatt, Jan
    Mikol, Daniel
    Cheng, Sunfa
    Lipton, Richard
    NEUROLOGY, 2019, 92 (15)
  • [27] Neurophysiological features of episodic and chronic migraine
    Sergeev, A.
    Abramova, A.
    Azimova, J.
    Tabeeva, G.
    JOURNAL OF NEUROLOGY, 2010, 257 : S60 - S61
  • [28] Efficacy of Erenumab in Chronic Migraine Patients with and Without Allodynia
    Lipton, R. B.
    Buse, D. C.
    Dodick, D. W.
    Richards, S.
    Klatt, J.
    Mikol, D. D.
    Cheng, S.
    Chou, D. E.
    HEADACHE, 2019, 59 : 101 - 101
  • [29] Psychological predictors of real-life experience with Erenumab in chronic migraine with or without medication overuse: data from a 1-year follow-up
    Bottiroli, S.
    Deicco, R.
    Vaghi, G.
    Fiammingo, G.
    Guaschino, E.
    Allena, M.
    Ghiotto, N.
    Tassorelli, C.
    Sances, G.
    JOURNAL OF HEADACHE AND PAIN, 2021, 22 (SUPPL 1): : 61 - 61
  • [30] Psychological predictors of real-life experience with Erenumab in chronic migraine with or without medication overuse: data from a 1-year follow-up
    Bottiroli, S.
    Deicco, R.
    Vaghi, G.
    Fiammingo, G.
    Guaschino, E.
    Allena, M.
    Ghiotto, N.
    Tassorelli, C.
    Sances, G.
    CEPHALALGIA, 2021, 41 (1_SUPPL) : 92 - 92
12345